Tag: Glooko

How Technologies Are Personalizing At-Home Diabetes Care

Mark Clements, MD, PhD

By Mark Clements, MD, PhD, CPI, FAAP, chief medical officer, Glooko, Inc.

Seemingly overnight, healthcare discovered and fully embraced digital health solutions. Just months after the 2020 nationwide lockdown, telehealth visits, virtual clinical trials and countless remote patient care technologies became the new normal.


Most of these technologies addressed what the American Medical Association calls “an epidemic” of chronic diseases. RPM solutions are especially suitable for these complex conditions, which typically require the frequent collection of physiological and/or patient-generated data from self-reporting tools, mobile devices, fitness wearables or other biosensors.

Diabetes has long been a focal point for technological innovations to personalize at-home patient care, beginning with the first glucose meters for patients in 1980. The need for such solutions has never been more urgent. A 2020 CDC report estimates that 122 million U.S. adults – one-third of the population — either have or are at risk of developing diabetes.

Here are three noteworthy recent advances in personalized diabetes care management that show the vast potential of digital health solutions to revolutionize both care management for chronic diseases and clinical research.

Continue Reading

Glooko Enables Remote Patient Care At No Charge To Medical Clinics and People with Diabetes To Minimize Risk During Pandemic

Throughout this challenging time of the COVID-19 pandemic, Glooko, a diabetes software company that enables people with diabetes and clinicians to manage care in real-time, is committed to helping ensure the health and well-being of people with diabetes, their caregivers, and their healthcare professionals. Glooko is therefore taking action to serve the global diabetes community by providing a no-charge remote-care solution that provides live patient-to-clinician connectivity.

Image result for glooko logoAs many efforts undertaken in our communities are aimed at reducing the chances of being exposed to and spreading COVID-19, individuals who have chronic conditions like diabetes and contract the virus appear to be at a higher risk for developing complications; as such limiting exposure is critical.

For certain appointments, healthcare professionals may determine that the patient and their care team would be best served by a remote review of the patient’s personal diabetes data and a corresponding telehealth consult, reserving in-office visits only for those appointments where a patient’s medical status truly requires in-person treatment.

To minimize the risk to people with diabetes during this time by broadening access to remote medical appointments with healthcare providers, Glooko is offering its secure, privacy-protected remote-care solution at no charge to medical clinics and people with diabetes as a public service until the greatest threat of the pandemic has subsided.

This public service is being made available to medical clinics and people with diabetes in countries where Glooko technology is already provided. Interested medical clinics and people with diabetes can learn more about how to access the Glooko remote-care solution at www.glooko.com.